One month after an experimental procedure to transplant the heart of a genetically modified pig into a patient with end-stage heart disease, doctors say the heart is functioning on its own and ...

Lawrence Faucette, 58, had received a heart from a gene-edited pig on Sept. 20 after his own heart began to fail. He was not a candidate for a human heart transplant because his medical condition ...

For the second time ever, a pig heart has been transplanted into a living human recipient, the University of Maryland Medical Center announced on Friday.

Lawrence Faucette, 58, was the second person in the world to undergo a pig heart transplant. He died Monday after his body showed signs of rejection, doctors said.

In this photo provided by the University of Maryland School of Medicine, surgeons perform a pig heart transplant into Lawrence Faucette at the school’s hospital in Baltimore, Md., in September 2023.

Surgeons have transplanted a pig’s heart into a dying man in a bid to prolong his life – only the second patient to ever undergo such an experimental feat. Two days later, the man was cracking ...

And it could not be better timed—the first US-based clinical trials of pig kidney transplantation into living humans begin ...

The second pig heart transplant recipient in history is recovering. Is this the future of organ transplants? By Rae Hodge. Published October 23, 2023 2:20PM (EDT) ...

Topline. Surgeons with the University of Maryland Medical Center were able to successfully transplant a pig’s heart into 58-year-old Lawrence Faucette on Wednesday, who was facing death with end ...

The first person to receive a genetically engineered pig heart, David Bennett, survived for two months after undergoing the groundbreaking procedure in January 2022. He died of sudden heart failure.

Six weeks after an experimental transplant operation, the second living person to receive a genetically modified pig heart has died, doctors reported. Lawrence Faucette was 58.

For the second time ever, a pig heart has been transplanted into a living human recipient, the University of Maryland Medical Center announced on Friday.